FDA contraindications for Zepbound include: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Prior serious hypersensitivity reaction to tirzepatide or any product components Patients requiring careful risk assessment regarding pancreatitis include: History of pancreatitis : The FDA label notes that it is unknown whether patients with a history of pancreatitis are at increased risk while using tirzepatide, as these patients were excluded from clinical trials
Lets break it down with real science
The delay of gastric emptying with semaglutide may influence the absorption of concomitantly administered oral medicinal products [see Drug Interactions (7.2)]
[DOI] [PMC free article] [PubMed] [Google Scholar] 22.Apostolopoulos V., Bojarska J., Chai T.-T., Elnagdy S., Kaczmarek K., Matsoukas J., New R., Parang K., Lopez O.P., Parhiz H., et al
Gastroparesis (stomach paralysis) is another potential serious effect
Safety Considerations Before Choosing a Lower-Cost Option If youre exploring affordable tirzepatide options, a few safeguards matter
